STOP PRESS
A few observations from an Engineer that I hold in very high regard...yeah he may also reside in the West (Yeah I'm due for a trip over there)...
1) That RRV study had implications of "Statistical Significance" despite it being of relative low N value.
2) Guys, this is serum observation, what that of synovial when you and I BOTH know that Synovium biomarkers are much more factored compared to serum?!
3) How many patients in our RRV study? 300? no
130?
Not quite
50? Think less
29? Guess again
Sh*t it was 18
Nah..even that was 11 iPPS and 7 were Placebo....
11 patients gave us such a stellar RESULT?
What is 002 and 003 with their 1000 plus patients going to eventuate in?
My exposure to PAR is low compared to what I and others research
(Thats terribly speculative...ignore that last statement, HR will have a field day)
The Humira comparative, and how about a bonus?, page-2
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 387930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 65468 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |